Literature DB >> 31737521

Feasibility of oxygen sensitive cardiac magnetic resonance of the right ventricle in pulmonary artery hypertension.

Karthigesh Sree Raman1,2,3, Michael Stokes4, Angela Walls5, Rebecca Perry1,2,3, Peter M Steele4, Christine Burdeniuk2, Carmine G De Pasquale1,2, David S Celermajer6,7, Joseph B Selvanayagam1,2,3.   

Abstract

BACKGROUND: Progressive right ventricular (RV) dysfunction in pulmonary arterial hypertension (PAH) which is contributed by RV ischemia leads to adverse clinical outcomes. Oxygen-sensitive (OS) cardiovascular magnetic resonance (CMR) has been used to determine the in vivo myocardial oxygenation of the left ventricle (LV). The aims of the present study were therefore to determine the feasibility of RV targeted rest/stress OS-CMR imaging in PAH patients and healthy volunteers.
METHODS: We prospectively recruited 20 patients with right heart catheter proven PAH and 9 healthy age matched controls (NC). The CMR examination involved standard functional imaging and OS-CMR imaging. An OS-CMR signal intensity (SI) index (stress/rest SI) was acquired at RV anterior, RV free-wall and RV inferior segments. In the LV, the OS-CMR SI index was acquired globally.
RESULTS: Reliable OS SI changes were only obtained from the RV inferior segment. As RV dysfunction in PAH is a global process, hence this segment was used in both patients and NC for further comparison. RV OS-CMR SI change between rest and stress in the NC was 17%±5% (mean ± SD). Nine of 20 (45%) of the PAH patients had a mean OS SI change of less than 9% (or ≥2 SD different from the mean values in NC). Overall, RV OS SI index between the PAH patients and NC was 11%±9% vs. 17%±5% (P=0.045) in the RV inferior segment. In the LV, the global OS-CMR SI index between the PAH patients and NC was 11%±7% vs. 21%±9% (P=0.019). There was a strong correlation between RV Inf OS-CMR SI and LV OS-CMR SI (r=0.86, P<0.001).
CONCLUSIONS: In this small pilot study, pharmacological induced OS-CMR is a feasible and safe technique to identify and study myocardial oxygenation in the RV of PAH patients. 2019 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Pulmonary artery hypertension; cardiac magnetic resonance (CMR); microcirculation; microvascular ischemia; oxygen-sensitive cardiac magnetic resonance

Year:  2019        PMID: 31737521      PMCID: PMC6837908          DOI: 10.21037/cdt.2019.09.19

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  27 in total

Review 1.  Pulmonary arterial hypertension.

Authors:  Vallerie V McLaughlin; Michael D McGoon
Journal:  Circulation       Date:  2006-09-26       Impact factor: 29.690

Review 2.  The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension.

Authors:  Harm J Bogaard; Kohtaro Abe; Anton Vonk Noordegraaf; Norbert F Voelkel
Journal:  Chest       Date:  2009-03       Impact factor: 9.410

3.  Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field.

Authors:  K R Thulborn; J C Waterton; P M Matthews; G K Radda
Journal:  Biochim Biophys Acta       Date:  1982-02-02

4.  Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol.

Authors:  Minako Oikawa; Yutaka Kagaya; Hiroki Otani; Masahito Sakuma; Jun Demachi; Jun Suzuki; Tohru Takahashi; Jun Nawata; Tatsuo Ido; Jun Watanabe; Kunio Shirato
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

Review 5.  Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension.

Authors:  John J Ryan; Stephen L Archer
Journal:  Circulation       Date:  2015-05-12       Impact factor: 29.690

6.  Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.

Authors:  Lin Piao; Yong-Hu Fang; Kishan Parikh; John J Ryan; Peter T Toth; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2013-06-21       Impact factor: 4.599

7.  The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.

Authors:  Lin Piao; Yong-Hu Fang; Virgilio J J Cadete; Christian Wietholt; Dalia Urboniene; Peter T Toth; Glenn Marsboom; Hannah J Zhang; Idith Haber; Jalees Rehman; Gary D Lopaschuk; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2009-12-01       Impact factor: 4.599

8.  Assessment of regional myocardial oxygenation changes in the presence of coronary artery stenosis with balanced SSFP imaging at 3.0 T: theory and experimental evaluation in canines.

Authors:  Rohan Dharmakumar; Jain Mangalathu Arumana; Richard Tang; Kathleen Harris; Zhouli Zhang; Debiao Li
Journal:  J Magn Reson Imaging       Date:  2008-05       Impact factor: 4.813

9.  Feasibility of cardiovascular magnetic resonance to detect oxygenation deficits in patients with multi-vessel coronary artery disease triggered by breathing maneuvers.

Authors:  Kady Fischer; Kyohei Yamaji; Silvia Luescher; Yasushi Ueki; Bernd Jung; Hendrik von Tengg-Kobligk; Stephan Windecker; Matthias G Friedrich; Balthasar Eberle; Dominik P Guensch
Journal:  J Cardiovasc Magn Reson       Date:  2018-05-07       Impact factor: 5.364

10.  Effect of Gd-DTPA-BMA on blood and myocardial T1 at 1.5T and 3T in humans.

Authors:  Puneet Sharma; Josh Socolow; Salil Patel; Roderic I Pettigrew; John N Oshinski
Journal:  J Magn Reson Imaging       Date:  2006-03       Impact factor: 4.813

View more
  3 in total

Review 1.  Microvascular Dysfunction as a Systemic Disease: A Review of the Evidence.

Authors:  Daniel S Feuer; Eileen M Handberg; Borna Mehrad; Janet Wei; C Noel Bairey Merz; Carl J Pepine; Ellen C Keeley
Journal:  Am J Med       Date:  2022-04-23       Impact factor: 5.928

Review 2.  Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop.

Authors:  Jane A Leopold; Steven M Kawut; Micheala A Aldred; Stephen L Archer; Ray L Benza; Michael R Bristow; Evan L Brittain; Naomi Chesler; Frances S DeMan; Serpil C Erzurum; Mark T Gladwin; Paul M Hassoun; Anna R Hemnes; Tim Lahm; Joao A C Lima; Joseph Loscalzo; Bradley A Maron; Laura Mercer Rosa; John H Newman; Susan Redline; Stuart Rich; Franz Rischard; Lissa Sugeng; W H Wilson Tang; Ryan J Tedford; Emily J Tsai; Corey E Ventetuolo; YouYang Zhou; Neil R Aggarwal; Lei Xiao
Journal:  Circ Heart Fail       Date:  2021-06-15       Impact factor: 10.447

3.  Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension.

Authors:  Karthigesh Sree Raman; Ranjit Shah; Michael Stokes; Angela Walls; Richard J Woodman; Rebecca Perry; Jennifer G Walker; Susanna Proudman; Carmine G De Pasquale; David S Celermajer; Joseph B Selvanayagam
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-08       Impact factor: 5.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.